ImpediMed Limited (ASX:IPD) Just Reported, And Analysts Assigned A AU$0.021 Price TargetSimplywall·Aug 30 at 12:18 AM
Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF), Clinuvel Pharmaceuticals (OtherCLVLF) and Impedimed Limited (OtherIPDQF)businessinsider·Aug 28 at 05:45 AMCUVL-1.33%
12:15 ETSOZO® Digital Health Platform Receives FDA Clearance for Sarcopenia Risk Assessmentprnewswire·Aug 18 at 04:16 PM
IPD: Q4 FY26 delivered revenue growth, strong cash position, and expanded reimbursement coverageQuartr·Jul 27 at 10:55 PM
Impedimed cancels lapsed options and performance rights, clarifying capital structureTip Ranks·Jul 3 at 05:24 AM
IPD and ABB Help Power Sustainable Operations at New Sydney Fish MarketPR Newswire·Jun 22 at 09:40 AMABBNY-2.68%
ImpediMed Broadens Breast Cancer Survivorship Monitoring with the SOZO® Digital Health Platform at ASBrS 2026Unusual Whales·May 1 at 03:03 PM
ImpediMed Director Parmjot Bains Steps Down, Retains Significant Equity InterestsTip Ranks·Apr 8 at 05:25 AM
